Q2 2026 Holdings
Filed 2026-08-14 | 19 holdings | $213.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Invesco QQQ TRPut | PUT | 46090E953 | $36.8M | 50,000 | 17.3% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $27.3M | 3,262,542 | 12.8% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $23.9M | 11,414,285 | 11.2% |
| NRX Pharmaceuticals Inc(NRXP) | COM NEW | 629444209 | $16.7M | 4,091,767 | 7.9% |
| Faeth Therapeutics Inc(SNSE) | COM NEW | 81728A207 | $15.3M | 610,169 | 7.2% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $12.3M | 1,800,556 | 5.8% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $11.1M | 33,237 | 5.2% |
| Cellectis S A(CLLS) | SPON ADS | 15117K103 | $9.8M | 3,281,501 | 4.6% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $8.6M | 450,646 | 4.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $7.5M | 140,000 | 3.5% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $7.1M | 75,000 | 3.4% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $6.2M | 1,500,000 | 2.9% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $6.2M | 70,000 | 2.9% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $5.4M | 764,243 | 2.5% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $4.8M | 175,706 | 2.3% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $4.7M | 67,500 | 2.2% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $4.5M | 135,000 | 2.1% |
| Sight Sciences Inc(SGHT) | COM | 82657M105 | $3.7M | 970,000 | 1.7% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $976.0K | 200,000 | 0.5% |